Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem Cells
- PMID: 29429153
- PMCID: PMC5824026
- DOI: 10.14348/molcells.2018.2227
Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem Cells
Abstract
Cancer preventive activities of green tea and its main constituent, (-)-epigallocatechin gallate (EGCG) have been extensively studied by scientists all over the world. Since 1983, we have studied the cancer chemopreventive effects of EGCG as well as green tea extract and underlying molecular mechanisms. The first part of this review summarizes ground-breaking topics with EGCG and green tea extract: 1) Delayed cancer onset as revealed by a 10-year prospective cohort study, 2) Prevention of colorectal adenoma recurrence by a double-blind randomized clinical phase II trial, 3) Inhibition of metastasis of B16 melanoma cells to the lungs of mice, 4) Increase in the average value of Young's moduli, i.e., cell stiffness, for human lung cancer cell lines and inhibition of cell motility and 5) Synergistic enhancement of anticancer activity against human cancer cell lines with the combination of EGCG and anticancer compounds. In the second part, we became interested in cancer stem cells (CSCs). 1) Cancer stem cells in mouse skin carcinogenesis by way of introduction, after which we discuss two subjects from our review on human CSCs reported by other investigators gathered from a search of PubMed, 2) Expression of stemness markers of human CSCs compared with their parental cells, and 3) EGCG decreases or increases the expression of mRNA and protein in human CSCs. On this point, EGCG inhibited self-renewal and expression of pluripotency-maintaining transcription factors in human CSCs. Human CSCs are thus a target for cancer prevention and treatment with EGCG and green tea catechins.
Keywords: AFM; Nanog; Oct4; Sox2; stemness.
Figures
Similar articles
-
Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate.J Cancer Res Clin Oncol. 2017 Dec;143(12):2401-2412. doi: 10.1007/s00432-017-2515-2. Epub 2017 Sep 23. J Cancer Res Clin Oncol. 2017. PMID: 28942499 Free PMC article. Review.
-
Biophysical Approach to Mechanisms of Cancer Prevention and Treatment with Green Tea Catechins.Molecules. 2016 Nov 18;21(11):1566. doi: 10.3390/molecules21111566. Molecules. 2016. PMID: 27869750 Free PMC article. Review.
-
Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds.J Cancer Res Clin Oncol. 2015 Sep;141(9):1511-22. doi: 10.1007/s00432-014-1899-5. Epub 2014 Dec 28. J Cancer Res Clin Oncol. 2015. PMID: 25544670 Review.
-
Epigallocathechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell lines.BMC Complement Altern Med. 2012 Oct 30;12:201. doi: 10.1186/1472-6882-12-201. BMC Complement Altern Med. 2012. PMID: 23110507 Free PMC article.
-
Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics.Int J Cancer. 2012 Jul 1;131(1):30-40. doi: 10.1002/ijc.26323. Epub 2011 Aug 25. Int J Cancer. 2012. PMID: 21796625 Free PMC article.
Cited by
-
Natural products reverse cancer multidrug resistance.Front Pharmacol. 2024 Mar 8;15:1348076. doi: 10.3389/fphar.2024.1348076. eCollection 2024. Front Pharmacol. 2024. PMID: 38572428 Free PMC article. Review.
-
From immune checkpoints to therapies: understanding immune checkpoint regulation and the influence of natural products and traditional medicine on immune checkpoint and immunotherapy in lung cancer.Front Immunol. 2024 Feb 15;15:1340307. doi: 10.3389/fimmu.2024.1340307. eCollection 2024. Front Immunol. 2024. PMID: 38426097 Free PMC article. Review.
-
A druggable conformational switch in the c-MYC transactivation domain.Nat Commun. 2024 Feb 29;15(1):1865. doi: 10.1038/s41467-024-45826-7. Nat Commun. 2024. PMID: 38424045 Free PMC article.
-
Computational insights into the stereo-selectivity of catechins for the inhibition of the cancer therapeutic target EGFR kinase.Front Pharmacol. 2024 Jan 11;14:1231671. doi: 10.3389/fphar.2023.1231671. eCollection 2023. Front Pharmacol. 2024. PMID: 38273823 Free PMC article.
-
TRAIL-Sensitizing Effects of Flavonoids in Cancer.Int J Mol Sci. 2023 Nov 22;24(23):16596. doi: 10.3390/ijms242316596. Int J Mol Sci. 2023. PMID: 38068921 Free PMC article. Review.
References
-
- Affara N.I., Trempus C.S., Schanbacher B.L., Pei P., Mallery S.R., Bauer J.A., Robertson F.M. Activation of Akt and mTOR in CD34+/K15+ keratinocyte stem cells and skin tumors during multistage mouse skin carcinogenesis. Anticancer Res. 2006;26:2805–2820. - PubMed
-
- Beck B., Driessens G., Goossens S., Youssef K.K., Kuchnio A., Caauwe A., Sotiropoulou P.A., Loges S., Lapouge G., Candi A., et al. A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours. Nature. 2011;478:399–403. - PubMed
-
- Bettuzzi S., Brausi M., Rizzi F., Castagnetti G., Peracchia G., Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 2006;66:1234–1240. - PubMed
-
- Boumahdi S., Driessens G., Lapouge G., Rorive S., Nassar D., Le Mercier M., Delatte B., Caauwe A., Lenglez S., Nkusi E., et al. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature. 2014;511:246–250. - PubMed
-
- Boutwell R.K. The role of the induction of ornithine decarboxylase in tumor promotion. In: Hiatt H.H., Watson J.D., Winsten J.A., editors. Origins of Human Cancer. New York: Cold Spring Harbor Laboratory; 1977. pp. 773–783.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous